S&P 500 Futures
(0.37%) 5 173.75 points
Dow Jones Futures
(0.34%) 38 964 points
Nasdaq Futures
(0.28%) 18 051 points
Oil
(0.76%) $78.70
Gas
(2.15%) $2.19
Gold
(0.64%) $2 323.30
Silver
(2.14%) $27.26
Platinum
(0.78%) $972.80
USD/EUR
(-0.13%) $0.928
USD/NOK
(-0.49%) $10.82
USD/GBP
(-0.29%) $0.795
USD/RUB
(-0.29%) $91.19

リアルタイムの更新: Indivior PLC [INDV.L]

取引所: LSE 産業: Pharmaceuticals, Biotechnology & Life Sciences
最終更新日時4 5月 2024 @ 00:49

-0.35% £ 1 435.00

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 00:49):

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders...

Stats
本日の出来高 9 472.00
平均出来高 508 790
時価総額 1.95B
EPS £0 ( 2024-04-24 )
次の収益日 ( £0 ) 2024-07-25
Last Dividend £36.50 ( 2016-06-16 )
Next Dividend £0 ( N/A )
P/E 1 435.00
ATR14 £1.329 (0.09%)

ボリューム 相関

長: 0.09 (neutral)
短: 0.41 (neutral)
Signal:(45.139) Neutral

Indivior PLC 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Indivior PLC 相関 - 通貨/商品

The country flag -0.30
( neutral )
The country flag -0.60
( weak negative )
The country flag -0.38
( neutral )
The country flag -0.53
( weak negative )
The country flag 0.31
( neutral )
The country flag 0.30
( neutral )

Indivior PLC 財務諸表

Annual 2023
収益: £1.09B
総利益: £907.00M (82.98 %)
EPS: £0.0100
FY 2023
収益: £1.09B
総利益: £907.00M (82.98 %)
EPS: £0.0100
FY 2022
収益: £901.00M
総利益: £742.00M (82.35 %)
EPS: £-0.380
FY 2021
収益: £791.00M
総利益: £664.00M (83.94 %)
EPS: £1.410

Financial Reports:

No articles found.

Indivior PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Indivior PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.48%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend £10.40 2015-09-17
Last Dividend £36.50 2016-06-16
Next Dividend £0 N/A
Payout Date 2016-07-29
Next Payout Date N/A
# dividends 2 --
Total Paid Out £46.90 --
Avg. Dividend % Per Year 0.00% --
Score 1.12 --
Div. Sustainability Score 4.95
Div.Growth Potential Score 0
Div. Directional Score 1.992 --
Next Divdend (Est)
(2024-07-15)
£0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.12
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TUNE.L Dividend Knight 2023-05-11 Semi-Annually 10 0.37%
MFX.L Dividend Knight 2023-06-15 Annually 4 1.28%
CSH.L Dividend King 2023-05-18 Quarterly 8 3.39%
SBRY.L Dividend Knight 2023-06-08 Annually 33 2.92%
HSS.L Dividend Knight 2023-06-08 Sporadic 10 1.00%
BBY.L Dividend Knight 2023-10-26 Annually 32 1.58%
WJG.L Dividend Junior 2023-06-08 Annually 9 3.05%
MYI.L Dividend King 2023-07-06 Quarterly 52 2.04%
EBOX.L Dividend Knight 2023-08-17 Quarterly 2 1.68%
SOHO.L Dividend King 2023-09-14 Quarterly 7 3.87%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.001831.5009.9610.00[0 - 0.5]
returnOnAssetsTTM0.001021.2009.9710.00[0 - 0.3]
returnOnEquityTTM0.005421.500-1.051-1.576[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.9680.800-0.161-0.129[1 - 3]
quickRatioTTM0.5260.800-1.609-1.287[0.8 - 2.5]
cashRatioTTM0.2421.5009.7710.00[0.2 - 2]
debtRatioTTM0.144-1.5007.59-10.00[0 - 0.6]
interestCoverageTTM0.5531.000-0.906-0.906[3 - 30]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
freeCashFlowPerShareTTM-2.682.00-1.339-2.68[0 - 20]
debtEquityRatioTTM0.215-1.5009.14-10.00[0 - 2.5]
grossProfitMarginTTM0.8301.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.01921.000-1.616-1.616[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.1171.000-7.32-7.32[0.2 - 2]
assetTurnoverTTM0.5590.8009.607.68[0.5 - 2]
Total Score4.95

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM1 237.181.00010.000[1 - 100]
returnOnEquityTTM0.005422.50-0.676-1.576[0.1 - 1.5]
freeCashFlowPerShareTTM-2.682.00-0.892-2.68[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.2881.000-9.700[0.1 - 0.5]
Total Score-0.971

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。